CytoHub receives the Impact Award at The AI Summit @ Stanford
Contact us

Human cell
intelligence.

Built on real data from living human heart tissue, for drug discovery and development.

Heart today. Brain next. Every human cell and disease.

CardioVive human heart organoid with atrial, ventricular, neural and fibroblast cells
  • Imaging
  • Electrophysiology
  • Contractility
  • Single-cell RNA
  • Bioprocess
  • → CytoHub.AI
5paying customers, including 3 pharma
13human cell types in every tissue
3AI tools live on customer studies
8patent families

Member of J&J JLABS · NVIDIA Inception · AWS Startups

The gap

Drug development runs on too little real human data.

Animal models and flat cell cultures miss how human tissue responds, and the cost shows up late, in the clinic.

~90% of drug candidates that enter clinical trials fail.

Sun et al., Acta Pharm Sin B 2022

How it works

Many dimensions of data. One map of human biology.

Live Measure and learn Building Predict and test

The CytoHub data wheel: assays in, decisions out Six readouts from the same CardioVive tissue (imaging, electrophysiology, contractility, single-cell RNA and qPCR, flow cytometry and bioprocess) flow into CytoHub.AI. It supports drug safety, discovery, QA/QC batch release, potency assays and therapeutic development. Results design the next experiment. 01 Measure 02 Learn 03 Decide ImagingImmunofluorescence · live-cell LIVE ElectrophysiologyVoltage imaging · MEA · APD LIVE ContractilityMotion vectors · beat rate · force LIVE Single-cell RNACell types · expression · qPCR BUILDING Flow cytometryCell identity · purity LIVE Bioprocess0.1–15 L bioreactor · analytics LIVE DRUG SAFETYCardiotoxicity · arrhythmia DISCOVERYDisease signatures · targets QA / QCIdentity · purity · release POTENCY ASSAYSFunctional potency per lot THERAPEUTIC DEVELOPMENTHeartReady™ · efficacy CytoHub.AI● SI CORE One map of human cell biology 04 TESTResults design the next CardioVive experimentBUILDING The CytoHub data wheel: assays in, CytoHub.AI, decisions out, and back 01 Measure ImagingImmunofluorescence · live-cell LIVE ElectrophysiologyVoltage imaging · MEA · APD LIVE ContractilityMotion vectors · beat rate · force LIVE Single-cell RNACell types · expression · qPCR BUILDING Flow cytometryCell identity · purity LIVE Bioprocess0.1–15 L bioreactor · analytics LIVE 02 Learn · CytoHub.AI CytoHub.AI● SI CORE 03 Decide DRUG SAFETYCardiotoxicity · arrhythmia DISCOVERYDisease signatures · targets QA / QCIdentity · purity · release POTENCY ASSAYSFunctional potency per lot THERAPEUTIC DEVELOPMENTHeartReady™ · efficacy 04 TESTDesigns the next experiment
Illustrative. Imaging, electrophysiology, contractility, flow and bioprocess readouts run today; in-house sequencing, prediction and the closed loop are being built.

From wet lab to robotic lab

We are automating the lab that makes the data.

Each protocol we run by hand today is becoming a module on one robotic line: the same steps, every run.

Today
CytoHub wet lab with imaging and analysis instruments at J&J JLABS
Our wet labHand-run CardioVive protocols, imaging and analysis at J&J JLABS, San Diego.
Building
Robotic arm of the CytoHub automation module, in development
Module 01 · robotic closed loopGrow, dose, read and sequence on one automated line, feeding CytoHub.AI.
  1. Grow
  2. Dose
  3. Read
  4. Sequence
  5. Learn

Proof

The dish matches the clinic.

Ondansetron carries clinical warnings for QT prolongation and septal defects. In our founding lab’s published work, the same human heart tissue showed signals consistent with both.

APD ↑consistent with the QT warning
MYL2 ↓consistent with the septal-defect warning

Read the case study

Action potential traces lengthening with ondansetron dose
Action potentials lengthen with dose. Volmert et al., Nat Commun 2023.

A data map of every human cell and disease.

  1. TodayHeart

    Cardiac safety, arrhythmia and immune-cardiac data.

  2. NextBrain

    Neurotoxicity, on the same tissue, robotics and models.

  3. VisionEvery human cell

    One connected map of cells, drugs and outcomes.

Cardia Therapeutics

The same cells could repair the heart.

HeartReady™ is a cell therapy to rebuild heart muscle after a heart attack, developed separately by Cardia Therapeutics.

Explore Cardia
Latest news
  • Oct 2026

    Our founding lab defines “immunoids” in Cell Stem Cell

  • 2026

    Impact Award at The AI Summit @ Stanford

  • 2026

    Exclusive platform license executed with MSU

All news

Put human cell data to work on your next decision.

Pilot studies, data partnerships, investor meetings and Cardia Therapeutics partnerships.